化学
细胞外
药品
细胞外小泡
小泡
细胞生物学
生物物理学
生物化学
药理学
体内
作者
Xi Shi,Weilong He,Haiyue Xu,Rinki Dasgupta,Leonardo Clark,Helena M. Zeng,Ashwin Gupta,Nitya Mirle,Lief E. Fenno,Huiliang Wang
标识
DOI:10.1016/j.xcrp.2026.103560
摘要
Precise, noninvasive targeting and controlled drug release to the nervous system can transform both basic research and clinical therapy. Ultrasound combined with artificial carriers offers a promising approach for precise, noninvasive drug release. Here, we report a focused ultrasound (FUS)-responsive delivery system based on extracellular vesicles (EVs), which are naturally occurring, biocompatible phospholipid nanocarriers. To enable ultrasound responsiveness, the lipid-gas phase-transition material perfluoropentane (PFP) is co-encapsulated with therapeutic agents into EVs via low-temperature sonication. The resulting EVs are 100–200 nm in size and demonstrate efficient, on-demand release upon ultrasound stimulation. In primary cultured neurons, FUS-triggered release from EVs loaded with PFP and lidocaine suppresses neuronal activity with minimal cytotoxicity. We further demonstrate in vivo modulation of pain sensitivity in rats. Overall, this EV-based platform enables safe, ultrasound-activated drug delivery and supports therapeutic applications of lipid nanocarriers.
科研通智能强力驱动
Strongly Powered by AbleSci AI